Home / Inspections / 1098286

FDA Inspection 1098286 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567004

The FDA completed an inspection of Regenerative Biologics, Inc. on June 18, 2019 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 18, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Gainesville, FL (United States)

Facility

Other inspections at this facility

  • 1253781 (NAI Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012244 (NAI Wed Mar 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 914703 (NAI Thu Feb 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 829781 (NAI Wed May 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 721599 (NAI Wed Apr 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources